Julia Wu, ScD, lead researcher and epidemiologist, Harvard T.H. Chan School of Public Health’s Human Immunomics Initiative, Boston. Jacqueline Parchem, MD, maternal-fetal medicine specialist, McGovern Medical School, University of Texas Health Science Center, Houston. Christa Carrig, registered nurse; labor and delivery nurse, Massachusetts General Hospital, Boston. Andrea Edlow, MD, lead researcher and a maternal-fetal medicine … Read more
State governments had 1.7 crore vaccine doses with them, another two crore were in the supply pipeline. The government on Tuesday moved to fast-track the import of a new lot of vaccines, including ones made by Pfizer, Moderna and Johnson & Johnson, but details on the pricing and procurement of these vaccines remained unavailable. VK … Read more
April 13, 2021 — After receiving reports of a rare blood clot in people receiving the Johnson & Johnson COVID-19 vaccine, the FDA and the CDC have recommended a pause in the use of the vaccine, pending further investigation. Here, what you need to know: Why was the pause suggested? After reviewing … Read more
April 2, 2021 — As discussions about “vaccine passports” accelerate with more people worldwide completing their COVID-19 shots, ethical quandaries are coming into focus. Mark A. Hall, JD, of the schools of law and medicine at Wake Forest University in Winston-Salem, NC, and David M. Studdert, ScD, LLB, of the schools of law and … Read more
March 31, 201 — Are coronavirus variants behind the recent jump in COVID-19 cases in states such as Florida, Michigan, New Jersey, and New York? Does the relaxation of public health protection measures play a role as well? It depends on who you ask. Anthony Fauci, MD, cautioned that the recent rise in … Read more
News releases, Moderna: “Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Pediatric Population,” “Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Adolescents.” Clinical Trials.gov: “Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals.” Tina … Read more
March 17, 2021 — Aaron Goyang thinks his long bout with COVID-19 has finally come to an end, several weeks after getting his second dose of a vaccine. Goyang, who is 33 and is a radiology technician in Austin, Texas, thinks he got COVID-19 from some of the coughing, gasping patients he treated last … Read more
The AED 2021 is being jointly convened by the Ministry of External Affairs and Pune International Centre. India will export vaccines to 40 more countries, supplementing the list of more than 70 nations where it is exporting Covid 19 vaccines, external affairs minister S Jaishankar said on Friday. “India has lived up to its talk … Read more
The Moderna and Pfizer vaccines were tested before the discovery of variants from the United Kingdom, South Africa, and Brazil, meaning those two vaccines likely benefited from higher efficacy rates and more straightforward results. But once the Johnson & Johnson shot receives emergency use authorization, which could come shortly after a scheduled scientific committee … Read more
Feb. 17, 2021 — By the end of July, there should be enough COVID-19 vaccine doses to inoculate every adult in America. But as of Tuesday, just more than 71.5 million doses had been distributed, and more than 55 million of those shots had already been given. With more than 200 million adults in the … Read more